Merck & Co. Continues Oncology Expansion with US$2.75 B VelosBio Buy
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 11 (Table of Contents)
Published: 17 Nov-2020
DOI: 10.3833/pdr.v2020.i11.2569 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In another multibillion-dollar effort to bolster its oncology portfolio, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS